Irritable Bowel Syndrome News

Healio Gastroenterology presents the following report on the top 10 peer-tested stories from September 2021.

Patients simultaneously exposed to antibiotics and bowel purgative had slightly higher rates of surrogate irritable bowel syndrome outcomes than matched controls, according to study results.

Psyllium reduced inulin-induced colonic gas production among patients with Rome IV criteria irritable bowel syndrome, according to research published in Gut.

Compared with escitalopram, sensory adaptation training significantly improved hypersensitivity and bowel symptoms in irritable bowel syndrome with constipation, according to a study published in Clinical and Translational Gastroenterology.

Healio Gastroenterology presents the following reports on recent news in COVID-19.

Patients with irritable bowel syndrome had improved symptom severity and normalized gut microbiota while following a low-FODMAP diet combined with a gluten-free diet, according to data published in BMC Gastroenterology.

Healio Gastroenterology presents the following report on the top peer-tested stories in June.

Patients with irritable bowel syndrome who engaged in severe food avoidance and restriction experienced more severe IBS symptoms and a reduced quality of life, according to study results.

Compared with placebo, LinZess significantly decreased abdominal symptoms such as bloating, discomfort and pain in patients with irritable bowel syndrome with constipation, according to results published in the American Journal of Gastroenterology.

Researchers observed clinically and statistically meaningful improvements with Trulance in patients with chronic idiopathic constipation and irritable bowel syndrome with constipation with reduced quality of life.